Oceania · News · The Advertiser (Adelaide Now)
Long Shortz Optiscan: FDA submission opens path to US commercialisation
CEO and Managing Director Dr Camile Farah to discuss the company’s US FDA 510(k) submission for its InForm digital pathology device, a major milestone towards potential US…
Read the full article on The Advertiser (Adelaide Now) Sign in to saveMediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.adelaidenow.com.au)


